HNL Lab Medicine Announces Strategic Preferred Partnership with Agilent

HNL Lab Medicine is pleased to announce a new Strategic Preferred Partnership with Agilent Technologies, Inc., marking a significant step in advancing innovation and excellence in laboratory medicine. This collaboration underscores both organizations’ commitment to delivering cutting-edge diagnostic solutions and enhancing patient care across communities.

The partnership program is a revolutionary lab model built on three foundational pillars: delivering high-quality results, providing exceptional service to patients and providers, and fostering a sustainable financial model that supports reinvestment in employees, facilities, and equipment. Together under this new model for laboratory excellence, both organizations aim to ensure mutual success and innovation in the lab industry.

Agilent is a global leader in analytical and diagnostic solutions and brings its expertise in precision instrumentation, automation, and laboratory workflow optimization to this partnership.

“This partnership with HNL Lab Medicine not only reinforces our long-standing relationship but also lays the foundation for shared risk and mutual growth in the dynamic clinical diagnostic market,” said Ben Bourke, Associate Vice President of Agilent’s Healthcare Diagnostics business in the United States and Canada.

Agilent provides instruments, software, services, and consumables for laboratories in life sciences, diagnostics, and applied chemical markets. With a strong focus on innovation and reliability, Agilent supports laboratories worldwide in delivering accurate and timely results.

“This partnership with Agilent reinforces our commitment to innovation and excellence in laboratory medicine, ensuring we continue to deliver high-quality diagnostics that improve patient care,” said Warren Erdmann, Chief Operating Officer of HNL Lab Medicine.

HNL Lab Medicine’s vision of transforming laboratory medicine through strategic collaborations enables healthcare providers to offer timely and accurate diagnoses to their patients. By leveraging the combined strengths of HNL Lab Medicine and Agilent, this alliance will foster innovation, streamline processes, and ensure a higher standard of service delivery.

With this partnership, HNL Lab Medicine continues to demonstrate its leadership in laboratory medicine, working with trusted partners to address the evolving needs of the healthcare industry.